Melanotan II

Not FDA approvedMelanocortin Receptor AgonistWeight & metabolicGH axis & hormones
4.5

Neutral, BioHarmony verdict

BioHarmony score 4.5 out of 10

Melanotan II is a fast tanning and sexual-response peptide with a harsher safety tradeoff; Nelson 2012 reported rhabdomyolysis after a 6 mg injection. Its appetite and libido effects may be noticeable, but this report treats unregulated use as high risk.

Read full report

What is Melanotan II?

Melanotan II is an unapproved non-selective melanocortin peptide that can darken skin, suppress appetite, and produce sexual-response effects, but the same receptor breadth creates a serious safety problem. Melanotan II activates several melanocortin receptors, including MC1R for pigmentation and central pathways tied to appetite and libido. Melanotan II earns a low score because early human efficacy signals are small and verified case reports include PRES, rhabdomyolysis, renal infarction, melanoma, and dysplastic-nevus proliferation.

From the BioHarmony report, reviewed Sep 20, 2026.

Saved on this device only.

How it is thought to work

Non-selective melanocortin receptor activation

Safety watch-outs

  • New or rapidly changing mole, oral pigmentation, or bleeding lesion
  • Severe headache, confusion, vision change, chest pain, or neurologic symptoms
  • Priapism, severe abdominal pain, dark urine, or muscle pain after dosing

Full risk profile in the BioHarmony report.

Dosing as published

Source-reported figures only. This page does not calculate a personal dose.

No approved-label or study protocol is recorded for Melanotan II yet.

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Educator coverage (3)

Attributed viewpoints, separate from primary research.

Trust & sourcing

  1. Last revieweddone
  2. Next reviewupcoming
US approvalNot FDA approved
CompoundingWithdrawn from Category 2 nomination; eligibility is not established

FDA identifies immunogenicity and peptide-impurity concerns for compounded melanotan II and cites published reports of serious adverse events.

Primary sources

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.